Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients

References

• Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. doi:10.1016/S0140-6736(19)30956-031178151
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Lee VH, Lam KO, Chang AT, et al. Management of nasopharyngeal carcinoma: Is adjuvant therapy needed? J Oncol Pract. 2018;14(10):594–602. doi:10.1200/JOP.18.0021930312564
   PubMed Web of Science ®Google Scholar
• Huang SH, O’Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol. 2017;18(7):40. doi:10.1007/s11864-017-0484-y28555375
   PubMed Web of Science ®Google Scholar
• Khandia R, Munjal A. Interplay between inflammation and cancer. Adv Protein Chem Struct Biol. 2020;119:199–245. doi:10.1016/bs.apcsb.2019.09.00431997769
   PubMed Web of Science ®Google Scholar
• Mano Y, Shirabe K, Yamashita Y, et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013;258(2):301–305. doi:10.1097/SLA.0b013e318297ad6b23774313
   PubMed Web of Science ®Google Scholar
• Yang HJ, Jiang JH, Liu QA, et al. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection. Tumour Biol. 2017;39(6):1010428317707375. doi:10.1177/101042831770737528639906
   PubMedGoogle Scholar
• Ma JY, Liu Q. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: a meta-analysis. Int J Surg. 2018;50:67–71. doi:10.1016/j.ijsu.2018.01.00229329786
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. doi:10.1158/1078-0432.CCR-14-044225271081
   PubMed Web of Science ®Google Scholar
• Xu L, Yu S, Zhuang L, et al. Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients. Oncotarget. 2017;8(21):34954–34960. doi:10.18632/oncotarget.1686528430597
   PubMedGoogle Scholar
• Roma-Rodrigues C, Mendes R, Baptista PV. Targeting tumor microenvironment for cancer therapy. Int J Mol Sci. 2019;20(4):840. doi:10.3390/ijms20040840
   PubMed Web of Science ®Google Scholar
• Mansuri N, Birkman EM, Heuser VD, et al. Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome. Virchows Arch. 2021;478(4):707–717. doi:10.1007/s00428-020-02932-332954467
   PubMed Web of Science ®Google Scholar
• Liang W, Ferrara N. The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunol Res. 2016;4(2):83–91. doi:10.1158/2326-6066.CIR-15-031326839309
   PubMed Web of Science ®Google Scholar
• Cen RX, Li YG. Platelet-to-lymphocyte ratio as a potential prognostic factor in nasopharyngeal carcinoma: a meta-analysis. Medicine. 2019;98(38):e17176. doi:10.1097/MD.000000000001717631567957
   PubMed Web of Science ®Google Scholar
• Chen YP, Zhao BC, Chen C, et al. Pretreatment platelet count improves the prognostic performance of the TNM staging system and aids in planning therapeutic regimens for nasopharyngeal carcinoma: a single-institutional study of 2626 patients. Chin J Cancer. 2015;34(3):137–146. doi:10.1186/s40880-015-0006-x25962816
   PubMedGoogle Scholar
• Olingy CE, Dinh HQ, Hedrick CC. Monocyte heterogeneity and functions in cancer. J Leukoc Biol. 2019;106(2):309–322. doi:10.1002/JLB.4RI0818-311R30776148
   PubMed Web of Science ®Google Scholar
• Teng JJ, Zhang J, Zhang TY, Zhang S, Li BS. Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis. Onco Targets Ther. 2016;9:37–47. doi:10.2147/OTT.S9445826730202
   PubMed Web of Science ®Google Scholar
• Qi Q, Zhuang L, Shen Y, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158–2167. doi:10.1002/cncr.3005727152949
   PubMed Web of Science ®Google Scholar
• Hua X, Long ZQ, Huang X, et al. The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer. Curr Probl Cancer. 2020;44(4):100560. doi:10.1016/j.currproblcancer.2020.10056032122667
   PubMed Web of Science ®Google Scholar
• Valero C, Pardo L, Sansa A, et al. Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma. Head Neck. 2020;42(2):336–343. doi:10.1002/hed.2601031750591
   PubMed Web of Science ®Google Scholar
• Yang S, Zhao K, Ding X, Jiang H, Lu H. Prognostic significance of hematological markers for patients with nasopharyngeal carcinoma: a meta-analysis. J Cancer. 2019;10(11):2568–2577. doi:10.7150/jca.2677031258763
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Scott JG, Berglund A, Schell MJ, et al. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. Lancet Oncol. 2017;18(2):202–211. doi:10.1016/S1470-2045(16)30648-927993569
   PubMed Web of Science ®Google Scholar
• Yao JJ, Qi ZY, Liu ZG, et al. Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis. Radiother Oncol. 2019;137:137–144. doi:10.1016/j.radonc.2019.04.02531102988
   PubMed Web of Science ®Google Scholar
• Kang Y, He W, Ren C. Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma. Signal Transduct Target Ther. 2020;5(1):245. doi:10.1038/s41392-020-00340-233093441
   PubMed Web of Science ®Google Scholar
• Ramadan S, Saka B, Yarikkaya E, Bilici A, Oncel M. The potential prognostic role of peritumoral eosinophils within whole tumor-associated inflammatory cells and stromal histological characteristics in colorectal cancer. Pol J Pathol. 2020;71(3):207–220. doi:10.5114/pjp.2020.9978733112111
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz MZ, Sierko E, Hempel D, Tucker SC, Honn KV. Platelets and cancer angiogenesis nexus. Cancer Metastasis Rev. 2017;36(2):249–262. doi:10.1007/s10555-017-9673-128681240
   PubMed Web of Science ®Google Scholar
• Chua ML, Tan SH, Kusumawidjaja G, et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: a pooled analysis of two randomised controlled trials. Eur J Cancer. 2016;67:119–129. doi:10.1016/j.ejca.2016.08.00627640138
   PubMed Web of Science ®Google Scholar
• Lu A, Li H, Zheng Y, et al. Prognostic significance of neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio, and platelet to lymphocyte ratio in patients with nasopharyngeal carcinoma. Biomed Res Int. 2017;2017:3047802. doi:10.1155/2017/304780228321405
   PubMed Web of Science ®Google Scholar
• Jin Y, Ye X, He C, Zhang B, Zhang Y. Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma. Head Neck. 2015;37(1):69–75. doi:10.1002/hed.2356524327524
   PubMed Web of Science ®Google Scholar
• Itatani Y, Yamamoto T, Zhong C. Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer. Proc Natl Acad Sci U S A. 2020;117(35):21598–21608. doi:10.1073/pnas.200811211732817421
   PubMed Web of Science ®Google Scholar
• Yang JG, Wang LL, Ma DC. Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases. Br J Haematol. 2018;180(3):321–334. doi:10.1111/bjh.1500029076133
   PubMed Web of Science ®Google Scholar
• Spiegel A, Brooks MW, Houshyar S, et al. Neutrophils suppress intraluminal NK cell-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discov. 2016;6(6):630–649. doi:10.1158/2159-8290.CD-15-115727072748
   PubMed Web of Science ®Google Scholar
• Deng Q, He B, Liu X, et al. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med. 2015;13(1):66. doi:10.1186/s12967-015-0409-025885254
   PubMed Web of Science ®Google Scholar
• He J, Lv P, Yang X, Chen Y, Liu C, Qiu X. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer. Tumour Biol. 2016;37(7):9037–9043. doi:10.1007/s13277-016-4793-826762408
   PubMedGoogle Scholar
• Farhan-Alanie OM, McMahon J, McMillan DC. Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2015;53(2):126–131. doi:10.1016/j.bjoms.2014.10.00725440150
   PubMed Web of Science ®Google Scholar
• Selzer E, Grah A, Heiduschka G, Kornek G, Thurnher D. Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer: comparative analysis of inflammation-based prognostic scoring systems. Strahlenther Onkol. 2015;191(6):486–494. doi:10.1007/s00066-014-0803-125583136
   PubMed Web of Science ®Google Scholar
• Peng RR, Liang ZG, Chen KH, Li L, Qu S, Zhu XD. Nomogram based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for predicting survival in nasopharyngeal carcinoma. J Inflamm Res. 2021;14:4019–4033. doi:10.2147/JIR.S32247534447260
   PubMed Web of Science ®Google Scholar
• Haemmerle M, Stone RL, Menter DG, Afshar-Kharghan V, Sood AK. The platelet lifeline to cancer: challenges and opportunities. Cancer Cell. 2018;33(6):965–983. doi:10.1016/j.ccell.2018.03.00229657130
   PubMed Web of Science ®Google Scholar
• Stoiber D, Assinger A. Platelet-leukocyte interplay in cancer development and progression. Cells. 2020;9(4):855. doi:10.3390/cells9040855
   PubMed Web of Science ®Google Scholar